Brought to you by 
Century Therapeutics brings in $250mm via Series A
08 Jul 2019
Executive Summary
Cell therapy start-up Century Therapeutics raised $250mm through its Series A round. Bayer AG, through its newly minted Leaps by Bayer venture investment arm, led with a $215mm investment and was joined by founder and seed investor Versant Ventures along with partner Fujifilm Cellular Dynamics.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Century Therapeutics brings in $250mm via Series A
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice